Phase I study of nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

Revisions in the International System for Staging Lung Cancer

Clifton F. Mountain · CHEST Journal · 1997 · 4.6K citations

Medicine, Oncology, Surgery +13

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara et al. · Journal of Clinical Oncology · 1999 · 1.5K citations

Medicine, Oncology, Radiation Oncology +12

Weekly <i>nab</i>-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

Mark A. Socinski, Igor Bondarenko, Nina Karaseva et al. · Journal of Clinical Oncology · 2012 · 754 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase III Study Comparing Second- and Third-Generation Regimens With Concurrent Thoracic Radiotherapy in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: West Japan Thoracic Oncology Group WJTOG0105

Nobuyuki Yamamoto, Kazuhiko Nakagawa, Yasumasa Nishimura et al. · Journal of Clinical Oncology · 2010 · 304 citations · Full text

Medicine, Oncology, Radiation Oncology +10